Ayşe Özaydın | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Prof. Ayşe Özaydın | Medicine and Dentistry | Best Researcher Award

Prof. Dr. (MD, MPH, PhD) at MarmaraÜniversitesi, Turkey

Prof. Dr. Ayşe Nilüfer (Gülersoy) Özaydın is a distinguished academic and public health expert with a career spanning over four decades. Born in Eskişehir, Turkey in 1959, she has contributed extensively to the fields of epidemiology, cancer prevention, reproductive health, and health education. She currently serves as a Professor in the Department of Public Health at Marmara University School of Medicine, Istanbul. Her vast experience includes roles as a guest lecturer at several medical schools, both in Turkey and Cyprus, and she has held key leadership positions in national health organizations and academic committees. Prof. Özaydın is a recognized figure in public health circles for her advocacy and pioneering work in breast cancer awareness and prevention. With numerous national and international affiliations, including WHO and GFMER, she has established herself as a thought leader and changemaker. Her work bridges clinical research, health policy, and education, impacting both public health systems and academic communities.

Professional Profile

Education

Prof. Dr. Özaydın’s academic journey began with a medical degree from Hacettepe University in 1984, followed by a master’s and Ph.D. in Public Health at the same institution. She further enhanced her expertise with postgraduate studies in Epidemiology and Statistics at the Liverpool School of Tropical Medicine in the UK. Over the years, she pursued a wide array of certifications in areas such as health education, reproductive health, clinical research methods, occupational health, and medical education, reflecting her commitment to lifelong learning and multidisciplinary expertise. She has completed advanced training courses at globally recognized institutions including Johns Hopkins University and the University of Maastricht. Her education is not only marked by academic degrees but by continuous professional development, particularly in emerging areas like cancer bioinformatics and qualitative research methods. This robust educational foundation has been critical in shaping her holistic and proactive approach to public health challenges in both academic and policy-making settings.

Professional Experience

Prof. Dr. Özaydın has accumulated extensive professional experience across clinical, academic, and governmental health sectors since beginning her career in 1984. She has worked as a physician in various public health centers across Turkey, assuming critical roles in immunization campaigns and women’s health services. Transitioning into academia, she joined Marmara University’s School of Medicine, where she advanced from lecturer to full professor in the Department of Public Health. Alongside her academic roles, she has served as a guest faculty member at institutions like Eastern Mediterranean University, Near East University, and Okan University. Her leadership includes appointments to advisory boards of the Turkish Ministry of Health, WHO initiatives, and national health strategy groups. In addition, she has held presidencies at key organizations such as the Breast Health Society (MEMEDER) and the Marmara Health Education and Research Foundation (MARSEV). Her professional record reflects deep engagement in both health system strengthening and medical education innovation.

Research Interest

Prof. Özaydın’s research interests are rooted in public health and focus extensively on breast cancer prevention, screening practices, and public awareness strategies. She is also deeply engaged in studies surrounding sexual and reproductive health, family planning, sexually transmitted infections, immunization programs, and occupational diseases. Her interdisciplinary approach merges clinical epidemiology with health education and behavior change communication. She has led and contributed to prevalence surveys, curriculum development projects, and national screening programs. Recently, she has explored newer research avenues like cancer bioinformatics and health-related social determinants in medical students. Her work is characterized by its direct impact on public health policy and community health improvement, with a particular emphasis on underserved populations. Prof. Özaydın’s research not only informs academic literature but also translates into practical guidelines and strategic plans for health ministries and global health bodies. Her studies are frequently published in peer-reviewed journals and presented at major international conferences.

Awards and Honors

Throughout her illustrious career, Prof. Özaydın has received numerous honors and appointments recognizing her academic and professional contributions. She is a valued member of the WHO Global Breast Cancer Initiative and has been invited to serve on scientific and advisory boards for Turkey’s Ministry of Health, including strategic task forces on cancer epidemiology and reproductive health. She was appointed president of MEMEDER and MARSEV, reflecting her leadership in health advocacy and education. Her contributions have been instrumental in developing national strategies for HIV/AIDS, family planning, and cancer screening. She has represented Turkey in multiple international collaborations and training programs, and her coordination role for the Geneva Foundation for Medical Education and Research highlights her global influence. Though specific award titles are not listed, her numerous appointments, leadership roles, and committee memberships across prestigious health and academic institutions serve as strong testaments to her recognition and esteem in the medical and scientific community.

Conclusion

Dr. Özaydın is a highly accomplished researcher with a distinguished career in public health, medical education, and epidemiology. Her expertise in areas like breast cancer prevention and reproductive health, along with her international collaborations and publications, positions her as a strong candidate for the Best Researcher Award. With a focus on expanding her interdisciplinary efforts and enhancing the global reach of her research, Dr. Özaydın’s contributions could be even more impactful in the future.

Publications Top Notes

  • Prevalence and risk factors of Helicobacter pylori in Turkey
    ➤ Authors: N. Özaydın, S.A. Turkyilmaz, S. Cali
    ➤ Citations: 264

  • Erkeklerde Cinsel Mitlere İnanma Oranları ve Mitlere İnanmayı Etkileyen Faktörler
    ➤Authors: F. Torun, S.D. Torun, A.N. Özaydın
    ➤ Citations: 127

  • Effect of extremely low frequency electromagnetic fields on growth rate and morphology of bacteria
    ➤ Authors: A. Inhan-Garip, B. Aksu, Z. Akan, D. Akakin, A.N. Özaydın, T. San
    ➤ Citations: 120

  • Assessment of sociodemographic and economic factors affecting immunization services in Istanbul
    ➤ Authors: H.H. Topuzoglu, A. Özaydın, G.A. Cali, D. Cebeci, S. Kalaca
    ➤ Citations: 102

  • Bahçeşehir’de oturan kadınların meme kanseri bilgi düzeyleri ve uygulamaları
    ➤ Authors: A.N. Özaydın, B.M. Güllüoğlu, P.C. Ünalan, S. Gorpe, B.R. Öner, et al.
    ➤ Citations: 71

  • Survey on a mammographic screening program in Istanbul
    ➤ Authors: V. Özmen, A.N. Özaydın, N. Cabioglu, B.M. Gulluoglu, P.C. Unalan, et al.
    ➤ Citations: 59

  • Türkiye’de evli erkeklerin aile planlaması yöntemlerini kullanmalarını etkileyen faktörler
    ➤Authors: L. Akın, N. Özaydın, D. Aslan
    ➤ Citations: 57

  • Sources of breast cancer knowledge and screening attendance – Moda, Istanbul
    ➤ Authors: A. Yildirim, A. Özaydın
    ➤ Citations: 50

  • Isotretinoin has no negative effect on attention, executive function and mood
    ➤ Authors: T. Ergun, D. Seckin, N. Özaydın, Ö. Bakar, A. Comert, et al.
    ➤ Citations: 47

  • Meme Kanserinde Tarama ve Tanı (İstanbul Konsensus Konferansı)
    ➤ Authors: S. Baskan, K. Atahan, E. Arıbal, N. Özaydın, P. Balcı, E. Yavuz
    ➤ Citations: 44

  • Cost-effectiveness of breast cancer screening in Turkey
    ➤ Authors: V. Özmen, S.Ö. Gürdal, N. Cabioğlu, B. Özcinar, A.N. Özaydın, et al.
    ➤ Citations: 38

  • Successful first round results of a Turkish breast cancer screening program
    ➤ Authors: A. Kayhan, S.Ö. Gürdal, N. Özaydın, N. Cabioglu, E. Ozturk, et al.
    ➤ Citations: 34

  • Diagnostic performance of AI for cancers in a mammography screening program
    ➤ Authors: I. Kizildag Yirgin, Y.O. Koyluoglu, M.E. Seker, S. Ozkan Gurdal, A.N. Özaydın, et al.
    ➤ Citations: 26

  • Dijital yerlilerin gözünden dijital okuryazarlık
    ➤ Authors: A. Özaydın, O. Kumral
    ➤ Citations: 23

  • The relationship between males’ attitudes to partner violence and contraception
    ➤ Authors: L. Akin, N. Özaydın
    ➤ Citations: 23

  • Kadın ve şiddet
    ➤ Authors: N. Özaydın, O. Üner, A. Akın
    ➤ Citations: 23

  • Bahçeşehir Meme Kanseri Tarama Projesi İlk Dönem Sonuçları
    ➤ Authors: A. Kayhan, S.Ö. Gürdal, N. Özaydın, E. Öztürk, N. Cabıoğlu, E. Arıbal
    ➤ Citations: 20

  • Care burden among informal caregivers of ALS patients
    ➤ Authors: Z. Tülek, A. Özakgül, N. Alankaya, A. Dik, A. Kaya, P.C. Ünalan, A.N. Özaydın, et al.
    ➤ Citations: 16

  • İstanbul/Moda’da kadınların meme kanseri bilgisi ve tarama katılımı
    ➤ Authors: A. Demir Yıldırım, A. Nilüfer Özaydın
    ➤ Citations: 16

  • İstenmeyen gebelikler ve düşüklerin kadın sağlığına etkileri
    ➤ Authors:  N. Özaydın, A. Akın
    ➤ Citations: 15

 

Alexander Kirichenko | Health Professions | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Alexander Kirichenko | Health Professions | Best Researcher Award

Professor Drexel University College of Medicine Drexellat at Allegheny General Hospital, United States

Dr. Alexander V. Kirichenko, MD, PhD, is a distinguished radiation oncologist and researcher with extensive expertise in stereotactic body radiotherapy (SBRT) and radiation biology. He currently serves as an Attending Radiation Oncologist at Allegheny General Hospital and System Director for Stereotactic Body Radiotherapy & Gastrointestinal Cancers Program at Allegheny Health Network Cancer Institute. With a career spanning over four decades, Dr. Kirichenko has made significant contributions to oncology research, particularly in hepatocellular carcinoma and functional treatment planning. His humanitarian efforts include leading international collaborations to advance radiation oncology care in Ukraine. A dedicated educator and innovator, Dr. Kirichenko has contributed to multiple clinical trials, patents, and book chapters, shaping the future of radiation oncology.

Professional Profile

Education

Dr. Kirichenko earned his MD from Kyiv Medical University, Ukraine, in 1981, followed by a residency in Radiation Oncology and Nuclear Medicine. He later obtained a PhD in Radiation Biology and a D.Sc. in Radiation Medicine. In pursuit of advanced training, he completed a postdoctoral fellowship at MD Anderson Cancer Center and obtained U.S. medical licensure from the University of Virginia. His residency training in General Surgery and Radiation Oncology at the University of Virginia further solidified his expertise. These rigorous academic and clinical experiences have enabled him to excel in both patient care and research.

Professional Experience

With a career dedicated to radiation oncology, Dr. Kirichenko has held various prestigious academic and clinical positions. He served as an Associate Professor at the Ukrainian National Cancer Institute and the University of Virginia before joining Allegheny General Hospital in 2006. As a leading expert, he has been involved in the development of advanced radiation therapies, including SBRT for liver malignancies. His work also extends to international collaborations, where he has played a pivotal role in enhancing global cancer care standards. His leadership within multiple healthcare institutions has made a lasting impact on cancer treatment methodologies.

Research Interests

Dr. Kirichenko’s research primarily focuses on radiation-induced toxicity, functional treatment planning, and advanced imaging techniques in radiation therapy. His studies on SBRT for hepatocellular carcinoma have contributed to improving survival outcomes while minimizing toxicity. He has also explored the use of superparamagnetic iron oxide nanoparticles (SPION) for enhancing MRI-guided radiotherapy. Through his involvement in numerous clinical trials and NIH-funded studies, he has pioneered innovative approaches in liver and rectal cancer treatment. His research continues to influence clinical practices, bridging the gap between experimental oncology and patient-centered care.

Awards and Honors

Throughout his career, Dr. Kirichenko has received numerous accolades for his contributions to radiation oncology. He has been recognized as one of the Best Doctors in America (2013–2023) and has received the Health Care Heroes Award from Pittsburgh Business Times. His leadership in national and international oncology projects has earned him appointments to expert panels, including the National Center for Biosecurity and Biodefense Preparedness. His extensive list of invited lectures, patents, and book chapters further reflects his commitment to advancing cancer research and treatment.

Conclusion

Dr. Alexander V. Kirichenko is a highly qualified and impactful researcher in radiation oncology with strong contributions to clinical innovation, translational research, and international collaboration. His extensive body of work, patents, leadership roles, and humanitarian contributions make him a strong candidate for the Best Researcher Award. If supplemented with further high-impact publications, mentorship initiatives, and policy engagements, his profile would be nearly unbeatable.

Publications Top Notes

  • Title: Chronomodulated chemotherapy and irradiation: An idea whose time has come?

  • Authors:

    • Tyvin A. Rich

    • Charles H. Shelton III

    • Alexander V. Kirichenko

    • Martin Straume

  • Journal: Chronobiology International

  • Year of Publication: 2002

  • Citations: 18 (as per available sources)

 

Nceba Gqaleni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Nceba Gqaleni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Research Professor at University of KwaZulu-Natal, South Africa

Professor Nceba Gqaleni is a renowned academic and researcher at the University of KwaZulu-Natal, South Africa. He currently serves as an Acting Academic Leader in the Discipline of Traditional Medicine and as a Research Professor. With a passion for integrating traditional medicine into mainstream healthcare, his research aims to address health challenges facing Africa, including HIV, diabetes, and cancer. His work on herbal treatments and immunomodulators has positioned him as a pioneer in exploring alternative therapies. Prof. Gqaleni’s research is characterized by the synergy between modern science and indigenous knowledge systems, contributing significantly to the global healthcare landscape. His work continues to impact public health, with ongoing clinical trials and innovative studies aimed at improving health outcomes. Additionally, he is committed to training the next generation of researchers, having mentored numerous postdoctoral, PhD, and master’s students.

Professional Profile

Education

Professor Nceba Gqaleni’s educational background is rooted in biochemistry, with a PhD in Biochemistry from the University of Strathclyde in Glasgow, UK. He also holds a Master’s degree in Biochemistry from the University of KwaZulu-Natal (UKZN), South Africa. His academic journey has been marked by a deep interest in both the molecular and traditional aspects of medicine, leading him to pursue research that bridges these fields. His formal education laid the foundation for a distinguished career in both academia and research, where he has applied his scientific expertise to explore alternative therapies and the integration of traditional medicine into contemporary health systems. Prof. Gqaleni’s educational path reflects a commitment to advancing knowledge and improving healthcare, particularly in the African context.

Professional Experience

Professor Gqaleni’s professional experience spans academia, research, and leadership. He currently holds the position of Acting Academic Leader in the Discipline of Traditional Medicine at the University of KwaZulu-Natal. His role involves guiding academic initiatives and research in traditional medicine, while also providing leadership in curriculum development and research supervision. In addition to his academic responsibilities, Prof. Gqaleni has led numerous significant research projects, particularly focused on traditional medicine’s role in addressing major health issues such as HIV and diabetes. His extensive work in supervising postgraduate students, including over 7 postdoctoral researchers, 12 PhD candidates, and 25 master’s students, demonstrates his dedication to nurturing the next generation of scholars and researchers. Prof. Gqaleni’s professional experience is a blend of academic excellence, mentorship, and groundbreaking research in the field of traditional medicine and biochemistry.

Research Interests

Professor Nceba Gqaleni’s research interests lie at the intersection of biochemistry and traditional medicine, with a primary focus on finding alternative treatments for diseases prevalent in Africa, such as HIV, diabetes, and cancer. He has led pioneering research on herbal compositions for the treatment of HIV and is currently conducting clinical trials for a patented HIV cure. In addition to HIV, his research extends to cancer therapies, immunomodulators, and the application of Indigenous phytotherapy in managing diseases like diabetes and HIV. Prof. Gqaleni’s ongoing research projects also explore the health and wellness of Indigenous peoples, particularly in the context of climate change and global health disparities. His work is driven by the goal of bridging the gap between traditional healing practices and modern medical approaches, thereby improving health outcomes in African communities and globally.

Awards and Honors

Professor Nceba Gqaleni’s career has been marked by significant achievements and recognition. He has been honored for his pioneering work in traditional medicine and biochemistry, particularly in the field of HIV and diabetes treatment. One of his notable accomplishments is the filing of a patent for a herbal composition aimed at curing HIV, which is currently undergoing clinical trials. Prof. Gqaleni has also received substantial funding for his research, including a $4.4 million NIH grant for a study on Indigenous phytotherapy. His contributions to science and public health have earned him the respect of both academic and medical communities. Prof. Gqaleni’s work in advancing the integration of traditional medicine into global health systems continues to garner international attention and recognition. His awards and honors reflect his exceptional leadership and groundbreaking contributions to healthcare research.

Conclusion

Professor Nceba Gqaleni demonstrates exceptional potential for the Best Researcher Award due to his innovative contributions to HIV treatment, integration of traditional medicine, and impactful mentorship. His work addresses critical health challenges in Africa, blending traditional knowledge with modern scientific methods. While broader dissemination and commercialization efforts could strengthen his profile, his contributions make him a strong contender for the award.

Publications Top Noted

  • Indigenous Medicinal Plants Used in the Management of Diabetes in Africa: 5 Years (2019–2024) in Perspective
    • Authors: Frimpong, E.K., Thembane, N., Hlatshwayo, S., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 2
  • Review on the Anti-Hyperglycemic Potential of Psidium guajava and Seriphium plumosum L.
    • Authors: Thembane, N., Hlatshwayo, S., Ngcobo, M., Ngubane, P., Gqaleni, N.
    • Year: 2024
    • Citations: 1
  • Erratum: An in vitro study to elucidate the effects of Product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors
    • Authors: Setlhare, B., Letsoalo, M., Nkabinde, S.A., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 0
  • An in vitro study to elucidate the effects of product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors
    • Authors: Setlhare, B., Letsoalo, M., Nkabinde, S.A., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 1
  • Analysis of Three Species of Cassipourea Traditionally Used for Hypermelanosis in Selected Provinces in South Africa
    • Authors: Mpofana, N., Yalo, M., Gqaleni, N., Dlova, N.C., Hussein, A.A.
    • Year: 2024
    • Citations: 0
  • Melasma in People with Darker Skin Types: A Scoping Review Protocol on Prevalence, Treatment Options for Melasma, and Impact on Quality of Life
    • Authors: Mpofana, N., Chibi, B., Gqaleni, N., Kgarosi, K., Dlova, N.C.
    • Year: 2023
    • Citations: 3
  • The Effect of Melasma on the Quality of Life in People with Darker Skin Types Living in Durban, South Africa
    • Authors: Mpofana, N., Paulse, M., Gqaleni, N., Hussein, A., Dlova, N.C.
    • Year: 2023
    • Citations: 0
  • The Met and Unmet Health Needs for HIV, Hypertension, and Diabetes in Rural KwaZulu-Natal, South Africa: Analysis of a Cross-Sectional Multimorbidity Survey
    • Authors: Singh, U., Olivier, S., Cuadros, D., Ramnanan, A., Harilall, S., Gqaleni, N.
    • Year: 2023
    • Citations: 5
  • An Investigation into the Acute and Subacute Toxicity of Extracts of Cassipourea flanaganii Stem Bark In Vivo
    • Authors: Mpofana, N., Chipangura, J.K., Paulse, M., Hussein, A.A., Crouch, N.R.
    • Year: 2023
    • Citations: 2
  • Treatment of Melasma on Darker Skin Types: A Scoping Review
    • Authors: Mpofana, N., Chibi, B., Visser, T., Hussein, A.A., Dlova, N.C.
    • Year: 2023
    • Citations: 4

 

Olga Moskalenko | Medicine | Best Researcher Award

Published on by World Top Scientists

Assoc Prof Dr. Olga Moskalenko | Medicine | Best Researcher Award

Candidate of Biological Sciences, Russia

Olga Leonidovna Moskalenko is a dedicated educator and researcher in the fields of pediatrics, psychology, and medical education. With extensive training in various medical and pedagogical disciplines, she has established herself as a prominent figure in her field. 🌟

Publication Profile

Scopus

Education

Olga graduated from the Krasnoyarsk State Medical Academy in 2005, specializing in Pediatrics. She has pursued multiple advanced training programs in Medical Informatics, Pedagogical Education, and Psychology, further enriching her knowledge and skills. 🎓

Experience

She currently serves as an Associate Professor at the Krasnoyarsk State Medical University, where she contributes to the Department of Histology, Cytology, and Embryology. Additionally, she holds the position of Senior Researcher at the Research Institute of Medical Problems of the North, showcasing her commitment to advancing medical research and education. 🏥

Research Interests

Olga’s research focuses on critical topics such as internet addiction in adolescents, psychological interviewing, and pathophysiology. Her work aims to address significant psychological and health issues impacting young people today. 🔬

Awards

Throughout her career, Olga has led numerous scientific projects and received grants for her research on internet addiction and cancer diagnostics, reflecting her dedication to improving health outcomes in her community. 🏆

Publications

Griffiths, M. D., & Moskalenko, O. L. (2024). Title of the Publication. Journal Name.

Moskalenko, O. L. (2021). Title of the Publication. Journal Name.

Moskalenko, O. L. (2020). Title of the Publication. Journal Name.

 

Carolin C. Hack | Medicine and Dentistry | Best Scholar Award

Published on by World Top Scientists

Dr. Carolin C. Hack | Medicine and Dentistry | Best Scholar Award

Deputy clinical director at Erlangen University Hospital Women’s Clinic, Germany

Priv.-Doz. Dr. med. Carolin Christine Hack is an accomplished medical professional and the Deputy Director of the Women’s Clinic at the University Hospital Erlangen. With a specialization in gynecological oncology and integrative medicine, Dr. Hack combines her clinical expertise with a passion for patient-centered care. Her innovative approach to medicine, along with her extensive training and research, positions her as a leading figure in her field.

Profile

Scopus

Education 🎓

Dr. Hack completed her medical degree at Friedrich-Alexander University Erlangen-Nuremberg, where she also pursued her habilitation in “Integrative Medicine in the Treatment of Gynecological Oncology Patients.” Her academic journey included a comprehensive curriculum that laid the groundwork for her clinical and research interests, ultimately leading to a robust foundation in both conventional and integrative medicine.

Experience 💼

With over a decade of experience at the University Hospital Erlangen, Dr. Hack has advanced through various roles, from assistant physician to Deputy Director of the Women’s Clinic. She has managed quality assurance initiatives and specialized in integrative medicine, focusing on the intersection of traditional and complementary therapies in patient care. Her leadership in the clinic has fostered a collaborative environment that emphasizes innovative treatment methodologies.

Research Interests 🔍

Dr. Hack’s research primarily focuses on integrative medicine and complementary therapy methods, with a specific emphasis on mammographic density as a risk factor for breast cancer. Her work seeks to enhance patient outcomes through evidence-based practices that incorporate holistic approaches to treatment.

Awards 🏆

Dr. Hack’s contributions to gynecological oncology have been recognized with multiple awards, including:

  • 2015: Klaus-Dieter-Schulz-Versorgungsforschungspreis
  • 2016: First Science Award from the German Society for Senology
  • 2018: Award from the Foundation for Women and Child Health
  • 2022: Research Award for Complementary Medicine from NATUM e.V.

Publications 📚

Dr. Hack has an extensive publication record, including:

  • The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
    • Authors: Ziegler, P., Hartkopf, A.D., Wallwiener, M., Schneeweiss, A., Goossens, C.
    • Journal: BMC Cancer
    • Year: 2024
    • Volume: 24(1), Article 1284
  • Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment
    • Authors: Schmidt, E., Distel, L., Erber, R., Fietkau, R., Schnellhardt, S.
    • Journal: Cancers
    • Year: 2024
    • Volume: 16(18), Article 3160
  • Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
    • Authors: Fasching, P.A., Hack, C.C., Nabieva, N., Fehm, T.N., Häberle, L.
    • Journal: European Journal of Cancer
    • Year: 2024
    • Volume: 209, Article 114239
  • Correlation of RANK and RANKL with mammographic density in primary breast cancer patients
    • Authors: Wunderle, M., Heindl, F., Behrens, A.S., Fasching, P.A., Emons, J.
    • Journal: Archives of Gynecology and Obstetrics
    • Year: 2024
    • Volume: 310(2), pp. 1223–1233
  • CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – An Overview of Current Programs
    • Authors: Schneeweiss, A., Brucker, S.Y., Huebner, H., Fehm, T.N., Fasching, P.A.
    • Journal: Geburtshilfe und Frauenheilkunde
    • Year: 2024
    • Volume: 84(5), pp. 443–458
  • Initial experience with a next-generation low-field MRI scanner: Potential for breast imaging?
    • Authors: Dietzel, M., Laun, F.B., Heiß, R., Uder, M., Ohlmeyer, S.
    • Journal: European Journal of Radiology
    • Year: 2024
    • Volume: 173, Article 111352
  • Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer
    • Authors: Heger, L., Heidkamp, G.F., Amon, L., Beckmann, M.W., Dudziak, D.
    • Journal: OncoImmunology
    • Year: 2024
    • Volume: 13(1), Article 2296713
  • Predicting mammographic density with linear ultrasound transducers
    • Authors: Behrens, A., Fasching, P.A., Schwenke, E., Beckmann, M.W., Emons, J.
    • Journal: European Journal of Medical Research
    • Year: 2023
    • Volume: 28(1), Article 384
  • Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows
    • Authors: Lehle, S., Emons, J., Hack, C.C., Ruebner, M., Huebner, H.
    • Journal: Scientific Reports
    • Year: 2023
    • Volume: 13(1), Article 373
  • Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
    • Authors: Hack, C.C., Maass, N., Aktas, B., Hein, A., Fasching, P.A.
    • Journal: Geburtshilfe und Frauenheilkunde
    • Year: 2023
    • Volume: 84(2), pp. 185–195

Conclusion ✨

Priv.-Doz. Dr. med. Carolin Christine Hack is an exemplary candidate for the Best Researcher Award. Her innovative contributions to integrative medicine and gynecological oncology, coupled with her extensive publication record and commitment to patient care, position her as a leader in her field. By addressing areas for improvement, such as interdisciplinary collaboration and public engagement, Dr. Hack can further enhance her impact in research and continue to advance the frontiers of medical knowledge.

Shahab Reaeian | Prevention | Best Researcher Award

Published on by World Top Scientists

Assoc Prof Dr. Shahab Reaeian | Prevention | Best Researcher Award

Academic member, Kermanshah University of Medical Sciences, Iran

Dr. Shahab Rezaeian is an esteemed epidemiologist from Iran, specializing in public health and epidemiology. With a PhD from Shiraz University of Medical Sciences, he has dedicated his career to understanding the dynamics of diseases and their impact on communities. He is currently a faculty member at Kermanshah University of Medical Sciences, contributing to the field through both research and education. 🩺📚

Publication Profile

Google scholar

Education

Dr. Rezaeian earned his B.S. in Public Health from Iran University of Medical Sciences in 2007, followed by an MSc in Epidemiology from Hamadan University of Medical Sciences in 2012. He completed his PhD in Epidemiology at Shiraz University of Medical Sciences in 2016, focusing his research on the survival trends and blood demand of beta-thalassemia patients. 🎓

Experience

Dr. Rezaeian has extensive experience in epidemiological research, particularly in assessing the risk factors for various health conditions, including congenital hypothyroidism and HIV. His professional journey reflects a commitment to advancing public health through rigorous data analysis and interpretation. 💼

Research Focus

His primary research interests include epidemiological modeling, public health interventions, and the study of congenital conditions. Dr. Rezaeian aims to contribute to effective health policies and practices by analyzing health data and identifying key determinants of health outcomes. 🔬📈

Awards and Honours

Dr. Rezaeian has received several accolades for his contributions to epidemiology and public health, including recognition for his impactful research publications and involvement in various health initiatives. His work continues to inspire future generations of health professionals. 🏆

Publication Top Notes

Dr. Rezaeian has authored numerous significant publications in reputable journals, contributing to the scientific community’s understanding of epidemiology and public health. Some notable works include:

Influenza A (H1N1) in Hamedan Province, Western Iran in 2009: A Case-Control Study (2010, J Res Health Sci) – Cited by 30

Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement (2011, Epidemiology and Health) – Cited by 50

The Quality of the Reporting of Randomized Controlled Trials after CONSORT Statement in the Prestigious Journals (2013, Shiraz E Medical Journal) – Cited by 40

Difference in the Incidence of Congenital Hypothyroidism Among World Countries (2013, Ann Saudi Med) – Cited by 20

Social Determinants of Health Associated with Self-Reported HIV Testing Among Women (2013, Iran J Public Health) – Cited by 35

Risk Factors of Congenital Hypothyroidism Using Propensity Score: A Matched Case-Control Study (2013, J Res Health Sci) – Cited by 25